Archived market update
This piece is kept for historical context (June 2026). For live quotes and coverage, see the stock hub or the monthly archive.
Looking to trade this stock? See our Interactive Brokers Canada review.
Get APTX alerts:
Apotex Health Corp's stock has seen a notable uptick, closing the last trading session at CA$29.75, reflecting a 1.40% gain.
In a market often marked by volatility, Apotex Health Corp (APTX.TO) is making a positive impression with its recent performance, closing up 1.40% in the latest trading session. This increase comes alongside recent developments surrounding the company's initial public offering, which has piqued investor interest.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$8.33B
P/E
21.9x
52W high
$40.18
52W low
$26.05
1W change
-3.75%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 13.2% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$40.69
+13.2% Upside
Current Price
C$35.95
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Investor takeaway: Investors should consider the potential long-term growth of Apotex Health Corp as it navigates its recent IPO and works to expand its market presence.
Market Cap Reaches CA$6.56 Billion
With a market cap of CA$6.56 billion, Apotex Health Corp is establishing itself as a significant player in the healthcare sector, drawing attention from investors.
Bull case
The successful completion of its upsized initial public offering has positioned Apotex Health Corp to tap into new capital for growth initiatives. This could enhance its market share and profitability as the company moves forward.
Bear case
Despite the recent gain, investors should stay cautious. The stock's performance is still early post-IPO, and market reactions can be unpredictable.
Recent Performance Overview
Apotex Health Corp's stock has shown resilience with a 1.40% increase, closing at CA$29.75. This performance stands out, especially given the company's recent IPO, which has generated significant interest among investors. The market cap now stands at CA$6.56 billion, reflecting strong investor confidence in its future prospects. For more details on its performance, check out the APTX.TO stock page.
Implications of the IPO
The upsized initial public offering has provided Apotex Health Corp with substantial capital, enabling it to pursue growth strategies and strengthen its market position. Investors are optimistic about the potential for increased profitability as the company effectively utilizes these funds. The recent IPO activities have positioned the company favorably within the competitive healthcare landscape. For further insights, visit the APTX.TO stock page.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
